The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 295.50
Bid: 294.50
Ask: 296.00
Change: -6.50 (-2.15%)
Spread: 1.50 (0.509%)
Open: 300.00
High: 304.00
Low: 291.50
Prev. Close: 302.00
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of New Chair

17 Dec 2020 07:00

RNS Number : 9240I
Synthomer PLC
17 December 2020
 

17th December 2020

 

Synthomer plc ('Synthomer' or 'the Company')

 

Appointment of New Chair

 

Synthomer announces that on 16th December Neil Johnson stepped down as Chairman of the Company after nine years on the Board, eight of which have been as Chair.

 

As announced on 30th March 2020, the Board is pleased to confirm that Caroline Johnstone has succeeded Neil as Chair of Synthomer. Caroline joined the Board as a non-executive director in 2015, where she has been Chair of the Audit Committee and a member of the Nomination and Remuneration Committees. Cynthia Dubin will replace Caroline as Chair of the Audit Committee.

 

Caroline has nearly 40 years' experience of working with chemicals and other large global organisations. Her experience includes delivering value from mergers and acquisitions, culture change and cost optimisation. She was a partner in PricewaterhouseCoopers (PwC) and sat on the Board of its UK Assurance practice, with responsibility for all people matters. Caroline is a chartered accountant and a member of the Institute of Chartered Accountants of Scotland. She is a non-executive director of Spirax Sarco Engineering plc and Shepherd Building Group Limited, a private company which owns the Portakabin business. She also has an honorary position on the governing board of the University of Manchester. 

 

Neil Johnson commented:

 

"It has been a pleasure serving on Synthomer's Board for the last nine years. During that time, the Company has successfully established itself as a leading, global, differentiated chemicals business. As confirmed in our recent Q3 trading update, Synthomer is benefiting from its clear strategy and effective business model and has proven resilient during the COVID-19 pandemic, with trading momentum across all divisions. Synthomer is well placed for the future, not least as it realises the benefits of the OMNOVA acquisition completed earlier this year.

 

I am delighted that I will be succeeded by Caroline, who has made a significant contribution to the Company during her time on the Board and who will preside over a business that I know can go from strength to strength." 

 

Caroline Johnstone commented:

 

"On behalf of the Board, I would like to thank Neil for the enormous contribution that he has made to the business over the last nine years. He has overseen a huge period of change and progress, and he leaves with our best wishes for the future. It is a privilege to succeed him as Chair and I look forward to working with other Board colleagues and the management team to take the business forward."

 

Enquiries:

 

Synthomer plc

Tel: + 44 7764 859147

Tim Hughes, President, Corporate Development

 

 

 

Teneo

Tel: + 44 7703 330 269

Charles Armitstead / Matt Denham

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZMMZRVDGGZM
Date   Source Headline
30th Jul 20197:00 amRNSResults of Rights Issue
26th Jul 20192:48 pmRNSDirector/PDMR Shareholding
26th Jul 20192:46 pmRNSDirector/PDMR Shareholding
24th Jul 20194:34 pmRNSDirector Declaration
15th Jul 20197:00 amRNSAdmission of Nil Paid Rights
10th Jul 20191:49 pmRNSPublication of Circular and Prospectus
10th Jul 20191:34 pmRNSDirector/PDMR Shareholding
3rd Jul 20197:00 amRNSAcquisition
2nd Jul 20193:56 pmRNSDirector Declaration
13th Jun 201911:18 amRNSDirector Declaration
25th Apr 20194:45 pmRNSResult of AGM
25th Apr 20197:00 amRNSQ1 Trading Update
10th Apr 20194:51 pmRNSDirector/PDMR Shareholding
10th Apr 20194:50 pmRNSDirector/PDMR Shareholding
10th Apr 20194:43 pmRNSDirector/PDMR Shareholding
10th Apr 20194:41 pmRNSDirector/PDMR Shareholding
28th Mar 20193:51 pmRNSDirector/PDMR Shareholding
28th Mar 20193:50 pmRNSDirector/PDMR Shareholding
25th Mar 20193:15 pmRNSAnnual Financial Report
21st Mar 20193:39 pmRNSDirector Declaration
18th Mar 201910:02 amRNSDirector/PDMR Shareholding
12th Mar 201911:25 amRNSDirector/PDMR Shareholding
12th Mar 201911:23 amRNSDirector/PDMR Shareholding
5th Mar 20194:09 pmRNSDirector/PDMR Shareholding
4th Mar 20197:00 amRNSResults for the year ended 31 December 2018
1st Mar 20193:26 pmRNSDirector Declaration
3rd Dec 201810:54 amRNSHolding(s) in Company
9th Nov 201811:36 amRNSDirector/PDMR Shareholding
6th Nov 20187:00 amRNSQ3 Trading update
17th Oct 20189:29 amRNSDirector Declaration
21st Sep 20189:17 amRNSDirectorate Change
6th Aug 20187:00 amRNSResults for the six months ended 30 June 2018
11th Jul 20186:25 pmRNSDirector/PDMR Shareholding
10th Jul 20189:47 amRNSHolding(s) in Company
4th Jul 201811:45 amRNSHolding(s) in Company
4th Jul 201811:44 amRNSHolding(s) in Company
4th Jul 201811:43 amRNSHolding(s) in Company
28th Jun 20183:12 pmRNSUpdate on Proposed Offering
25th Jun 20187:19 amRNSPROPOSED OFFERING OF EUR300M BOND & REFINANCING
21st Jun 201810:16 amRNSResult of Extraordinary General Meeting
8th Jun 20187:00 amRNSEuropean Commission investigation
4th Jun 20181:02 pmRNSNotice of GM
3rd May 20181:38 pmRNSHolding(s) in Company
2nd May 20184:29 pmRNSDirector/PDMR Shareholding
26th Apr 20182:23 pmRNSResult of AGM
26th Apr 20187:00 amRNSQ1 Trading update
9th Apr 20184:54 pmRNSDirector Declaration
27th Mar 20181:03 pmRNSDirector/PDMR Shareholding
27th Mar 20181:01 pmRNSDirector/PDMR Shareholding
26th Mar 20184:55 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.